DK0912537T3 - Fremgangsmåde til fremstilling af phenylheterocykliske forbindelser, der er anvendelige som cox-2-inhibitorer - Google Patents
Fremgangsmåde til fremstilling af phenylheterocykliske forbindelser, der er anvendelige som cox-2-inhibitorerInfo
- Publication number
- DK0912537T3 DK0912537T3 DK97932424T DK97932424T DK0912537T3 DK 0912537 T3 DK0912537 T3 DK 0912537T3 DK 97932424 T DK97932424 T DK 97932424T DK 97932424 T DK97932424 T DK 97932424T DK 0912537 T3 DK0912537 T3 DK 0912537T3
- Authority
- DK
- Denmark
- Prior art keywords
- cox
- inhibitors
- preparation
- compounds useful
- phenylheterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2120096P | 1996-07-03 | 1996-07-03 | |
GBGB9615867.0A GB9615867D0 (en) | 1996-07-03 | 1996-07-29 | Process of preparing phenyl heterocycles useful as cox-2 inhibitors |
PCT/US1997/011466 WO1998000416A1 (en) | 1996-07-03 | 1997-06-27 | Process of preparing phenyl heterocycles useful as cox-2 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0912537T3 true DK0912537T3 (da) | 2004-08-30 |
Family
ID=26309770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97932424T DK0912537T3 (da) | 1996-07-03 | 1997-06-27 | Fremgangsmåde til fremstilling af phenylheterocykliske forbindelser, der er anvendelige som cox-2-inhibitorer |
Country Status (26)
Country | Link |
---|---|
US (1) | US5840924A (zh) |
EP (1) | EP0912537B1 (zh) |
JP (1) | JP3071472B2 (zh) |
CN (1) | CN1097046C (zh) |
AR (1) | AR007695A1 (zh) |
AT (1) | ATE266651T1 (zh) |
AU (1) | AU717835B2 (zh) |
BR (1) | BR9710099A (zh) |
CA (1) | CA2258048C (zh) |
CZ (1) | CZ297257B6 (zh) |
DE (1) | DE69729096T2 (zh) |
DK (1) | DK0912537T3 (zh) |
EA (1) | EA001629B1 (zh) |
ES (1) | ES2218691T3 (zh) |
GB (1) | GB9615867D0 (zh) |
HK (1) | HK1017355A1 (zh) |
HR (1) | HRP970351B1 (zh) |
HU (1) | HU224840B1 (zh) |
NZ (1) | NZ333379A (zh) |
PL (1) | PL195025B1 (zh) |
PT (1) | PT912537E (zh) |
RS (1) | RS49591B (zh) |
SK (1) | SK283997B6 (zh) |
TW (1) | TW419474B (zh) |
UA (1) | UA57029C2 (zh) |
WO (1) | WO1998000416A1 (zh) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040072889A1 (en) * | 1997-04-21 | 2004-04-15 | Pharmacia Corporation | Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia |
JP2002506024A (ja) * | 1998-03-13 | 2002-02-26 | メルク エンド カムパニー インコーポレーテッド | 急性冠動脈虚血症候群および関連状態に対する併用療法および組成物 |
US6031108A (en) * | 1998-09-16 | 2000-02-29 | Bayer Corporation | Process for the preparation of 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole (TDA sulfone) |
US6649645B1 (en) | 1998-12-23 | 2003-11-18 | Pharmacia Corporation | Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia |
AU2001258677A1 (en) * | 2000-05-22 | 2001-12-03 | Dr. Reddy's Research Foundation | Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them |
US20060167074A1 (en) * | 2001-06-19 | 2006-07-27 | Norbert Muller | Methods and compositions for the treatment of psychiatric disorders |
DE10129320A1 (de) * | 2001-06-19 | 2003-04-10 | Norbert Mueller | Verwendung von COX-2 Inhibitoren zur Behandlung von Schizophrenie, wahnhaften Störungen, affektiven Störungen oder Ticstörungen |
AU2002214243A1 (en) * | 2001-10-10 | 2003-04-22 | Shasun Chemicals And Drugs Limited | 1-((4-methyl thio)phenyl)-2-(phenyl acetoxy)-1-ethanone and a process for preparing the same |
CA2472459A1 (en) * | 2002-01-10 | 2003-07-24 | Kong Teck Chong | Use of cox-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections |
TW200403072A (en) * | 2002-01-23 | 2004-03-01 | Upjohn Co | Combination therapy for the treatment of bacterial infections |
US20040147581A1 (en) * | 2002-11-18 | 2004-07-29 | Pharmacia Corporation | Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy |
US20040220155A1 (en) * | 2003-03-28 | 2004-11-04 | Pharmacia Corporation | Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith |
AU2004237438B2 (en) * | 2003-05-07 | 2011-01-20 | Osteologix A/S | Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions |
CA2519189C (en) * | 2003-05-07 | 2012-07-17 | Osteologix A/S | Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions |
WO2005009342A2 (en) * | 2003-07-16 | 2005-02-03 | Pharmacia Corporation | Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith |
US20050119262A1 (en) * | 2003-08-21 | 2005-06-02 | Pharmacia Corporation | Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent |
WO2005023189A2 (en) * | 2003-09-03 | 2005-03-17 | Pharmacia Corporation | Method of cox-2 selective inhibitor and nitric oxide-donating agent |
EP1784179A4 (en) | 2004-08-24 | 2010-03-31 | Merck Sharp & Dohme | COMBINATION THERAPY FOR THE TREATMENT OF CYCLOOXYGENASE-2-MEDIATED DISEASES OR CONDITIONS IN PATIENTS WITH RISK TO THROMBOTIC CARDIOVASCULAR EVENTS |
AU2006244393B2 (en) * | 2005-05-05 | 2012-06-21 | Cook Biotech Incorporated | Implantable materials and methods for inhibiting tissue adhesion formation |
CN104774186A (zh) * | 2015-04-28 | 2015-07-15 | 江苏中旗作物保护股份有限公司 | 农药除草剂异恶唑草酮的合成方法 |
EP3883562A4 (en) | 2018-11-21 | 2022-08-03 | Tremeau Pharmaceuticals, Inc. | PURIFIED FORMS OF ROFECOXIB AND METHODS OF MAKING AND USING |
US10945992B1 (en) | 2019-11-13 | 2021-03-16 | Tremeau Pharmaceuticals, Inc. | Dosage forms of rofecoxib and related methods |
US11161833B1 (en) | 2021-04-09 | 2021-11-02 | Tremeau Pharmaceuticals, Inc. | Deuterated etoricoxib, methods of manufacture, and use thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5916884A (ja) * | 1982-07-19 | 1984-01-28 | Fujisawa Pharmaceut Co Ltd | 新規フラン化合物 |
US4968817A (en) * | 1984-07-27 | 1990-11-06 | National Distillers And Chemical Corporation | Manufacture of gamma-crotonolactone by carbonylation of glycidol |
DE3615157A1 (de) * | 1986-05-05 | 1987-11-12 | Schwabe Willmar Gmbh & Co | 5-arylalkyl-4-alkoxy-2(5h)-furanone, zwischenprodukte und verfahren zu ihrer herstellung sowie ihre anwendung als therapeutische wirkstoffe |
DE3718527A1 (de) * | 1987-06-03 | 1988-12-15 | Basf Ag | Verfahren zur herstellung von 2(5h)-furanonen |
US5207817A (en) * | 1989-09-23 | 1993-05-04 | Bayer Aktiengesellschaft | Herbicidal 5H-furan-2-one derivatives |
DE4014420A1 (de) * | 1989-09-23 | 1991-04-04 | Bayer Ag | 5h-furan-2-on-derivate |
JPH05506215A (ja) * | 1990-04-17 | 1993-09-16 | アラーガン、インコーポレイテッド | 抗炎症剤としての5および/または4位で置換した2(5h)―フラノン |
US5393150A (en) * | 1991-09-05 | 1995-02-28 | Fort; Chris | Bifurcated keyboard arrangement |
IT1254558B (it) * | 1992-03-26 | 1995-09-25 | Mini Ricerca Scient Tecnolog | Composti a base di 3,4-diaril-(5h)-furan-2-one ad attivita' fungicida 3 |
ES2111288T3 (es) * | 1993-01-15 | 1998-03-01 | Searle & Co | Nuevos 3,4-diaril tiofenos y analogos de los mismos utiles como agentes antiinflamatorios. |
US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
KR960703901A (ko) * | 1993-08-19 | 1996-08-31 | 로즈 암스트롱 | 치환된 2(5H)푸라논, 2(5H)티오페논 및 2(5H)피롤론 유도체, 그의 제조 방법 및 엔도텔린 길항제로서의 그의 용도(Substituted 2(5H)Furanone, 2(5H)Thiophenone and 2(5H)Pyrrolone Derivatives, Their Preparation and Their Use as Endothelin antagonists) |
EP0739340A1 (en) * | 1994-01-10 | 1996-10-30 | Merck Frosst Canada Inc. | Phenyl heterocycles as cox-2 inhibitors |
US5475995A (en) * | 1994-05-16 | 1995-12-19 | Livingston; George G. | Truck spare tire locking rod |
-
1996
- 1996-07-29 GB GBGB9615867.0A patent/GB9615867D0/en active Pending
-
1997
- 1997-06-16 US US08/876,894 patent/US5840924A/en not_active Expired - Fee Related
- 1997-06-27 AT AT97932424T patent/ATE266651T1/de active
- 1997-06-27 CZ CZ0436898A patent/CZ297257B6/cs not_active IP Right Cessation
- 1997-06-27 DK DK97932424T patent/DK0912537T3/da active
- 1997-06-27 ES ES97932424T patent/ES2218691T3/es not_active Expired - Lifetime
- 1997-06-27 SK SK1793-98A patent/SK283997B6/sk not_active IP Right Cessation
- 1997-06-27 PT PT97932424T patent/PT912537E/pt unknown
- 1997-06-27 DE DE69729096T patent/DE69729096T2/de not_active Expired - Lifetime
- 1997-06-27 RS YUP-592/98A patent/RS49591B/sr unknown
- 1997-06-27 HR HR970351A patent/HRP970351B1/xx not_active IP Right Cessation
- 1997-06-27 EA EA199900079A patent/EA001629B1/ru not_active IP Right Cessation
- 1997-06-27 UA UA99020607A patent/UA57029C2/uk unknown
- 1997-06-27 CA CA002258048A patent/CA2258048C/en not_active Expired - Fee Related
- 1997-06-27 PL PL97330750A patent/PL195025B1/pl not_active IP Right Cessation
- 1997-06-27 JP JP10504411A patent/JP3071472B2/ja not_active Expired - Fee Related
- 1997-06-27 HU HU9903836A patent/HU224840B1/hu not_active IP Right Cessation
- 1997-06-27 CN CN97196133A patent/CN1097046C/zh not_active Expired - Fee Related
- 1997-06-27 EP EP97932424A patent/EP0912537B1/en not_active Expired - Lifetime
- 1997-06-27 NZ NZ333379A patent/NZ333379A/xx not_active IP Right Cessation
- 1997-06-27 WO PCT/US1997/011466 patent/WO1998000416A1/en active IP Right Grant
- 1997-06-27 BR BR9710099A patent/BR9710099A/pt not_active IP Right Cessation
- 1997-06-27 AU AU35886/97A patent/AU717835B2/en not_active Ceased
- 1997-06-28 TW TW086109096A patent/TW419474B/zh not_active IP Right Cessation
- 1997-07-01 AR ARP970102940A patent/AR007695A1/es active IP Right Grant
-
1999
- 1999-06-08 HK HK99102482A patent/HK1017355A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0912537T3 (da) | Fremgangsmåde til fremstilling af phenylheterocykliske forbindelser, der er anvendelige som cox-2-inhibitorer | |
DK1023266T3 (da) | Fremgangsmåde til fremstilling af diarylpyridiner, der kan anvendes som COX-2-inhibitorer | |
DK1386921T3 (da) | Mellemprodukter til fremstilling af anti-trombotiske 4H-cycolopenta-1,3-dioxol-derivater | |
DK1147114T3 (da) | Hidtil ukendt aralkylaminer af spirofuropyridiner, der er egnede til terapi | |
DK1001934T3 (da) | Indolforbindelser som COX-2-inhibitorer | |
DK1008577T3 (da) | Fremgangsmåde til fremstilling af methanol | |
DK1173431T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
DK1105382T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
DK0790226T3 (da) | Fremgangsmåde til fremstilling af methanol | |
DK0946512T3 (da) | 6-Phenylpyridyl-2-aminderivater, der er nyttige som NOS-inhibitorer | |
FI962800A0 (fi) | Fenyyliheterosyklisiä yhdisteitä COX-2 inhibiittoreina | |
DK1159274T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
DK0937055T3 (da) | Fremgangsmåde til fremstilling af d,I-alfa-tocopherol | |
DK1296935T3 (da) | Fremgangsmåde til fremstilling af substituerede octanoylamider | |
DK0925285T3 (da) | Fremgangsmåde til fremstilling af pyrimidinforbindelser | |
DK0996642T3 (da) | Fremgangsmåde til fremstilling af heparin | |
DK0928291T3 (da) | 3-Mercaptoacetylamino-1,5-substituerede 2-oxo-azepanderivater, der er nyttige som inhibitorer af matrixmetalloproteinase | |
DK1028960T3 (da) | Fremgangsmåde til fremstilling af thiazolidinedion | |
DK0946531T3 (da) | Fremgangsmåde til fremstilling af thiazol-derivater | |
DK0966444T3 (da) | Fremgangsmåde til fremstilling af pyrazolderivater | |
DK0970939T3 (da) | Fremgangsmåde til fremstilling af methanol | |
DK0880498T3 (da) | Fremgangsmåde til fremstilling af diketonforbindelser | |
DK0973769T3 (da) | Fremgangsmåde til fremstilling af eprosartan | |
DK0985733T3 (da) | Fremgangsmåde til fremstilling af cyclodextrin | |
DK0975594T3 (da) | Fremgangsmåde til fremstilling af indolderivater |